Legal Representation
Attorney
Brent D. Sokol
USPTO Deadlines
Application History
41 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 23, 2024 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Dec 23, 2024 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Apr 23, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 22, 2024 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Apr 22, 2024 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Apr 22, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 24, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 20, 2023 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Oct 20, 2023 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Oct 20, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 19, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 17, 2023 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| May 17, 2023 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| May 17, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 3, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Apr 3, 2023 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Apr 3, 2023 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Oct 27, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 25, 2022 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Oct 25, 2022 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Oct 25, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 21, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Oct 21, 2022 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
| Oct 21, 2022 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Oct 21, 2022 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| May 17, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Mar 22, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Mar 22, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 2, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Feb 17, 2022 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Feb 14, 2022 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Feb 11, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Feb 10, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 9, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 9, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jan 27, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jan 27, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jan 27, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jan 19, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 11, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 15, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 035
Recruitment advertisement services, namely, posting of clinical trial notices for the purpose of selecting and recruiting patients for clinical trials using patient biomarker data and genetic profiling data; Business research and data analysis in the field of pharmaceutical drug development, namely, selecting and analyzing patient data and genetic information to assist with measuring the performance of pharmaceuticals in the field of pharmaceutical drug development
Class 042
Providing the service of matching individuals with clinical trials; providing the service of collecting patient data and analysis of such data for identifying and recruiting patients for participation in clinical trials for pharmaceutical drug development, matching patients with clinical trials and for measuring and monitoring the performance of clinical trials for pharmaceutical drug development; providing the service of collecting and analyzing patient data and genetic information for pharmaceutical drug development
Additional Information
Pseudo Mark
PROMETHEUS THREE SIX ZERO; PROMETHEUS THREE HUNDRED SIXTY
Classification
International Classes
035
042